Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...
Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
15hon MSN
I had to man up and get a mammogram
Breast cancer isn't just a 'pink' disease; for men with a family history or genetic predisposition, a mammogram can be a ...
DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to ca ...
The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:00 AM EDTCompany ParticipantsMark Stolper - Executive VP ...
As Liz Cantor’s beloved mum Becky lay in a small cottage hospice on the Sunshine Coast, her daughter asked: “If you could ...
Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for ...
Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results